dc.contributor.author |
Grischke, Eva-Maria |
|
dc.date.accessioned |
2022-12-13T09:30:44Z |
|
dc.date.available |
2022-12-13T09:30:44Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
1470-2045 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/134122 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/S1470-2045(22)00159-0 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20220728000000_00962 |
|
utue.publikation.seiten |
625-635 |
de_DE |
utue.personen.roh |
Nitz, Ulrike |
|
utue.personen.roh |
Gluz, Oleg |
|
utue.personen.roh |
Graeser, Monika |
|
utue.personen.roh |
Christgen, Matthias |
|
utue.personen.roh |
Kuemmel, Sherko |
|
utue.personen.roh |
Grischke, Eva-Maria |
|
utue.personen.roh |
Braun, Michael |
|
utue.personen.roh |
Augustin, Doris |
|
utue.personen.roh |
Potenberg, Jochem |
|
utue.personen.roh |
Krauss, Katja |
|
utue.personen.roh |
Schumacher, Claudia |
|
utue.personen.roh |
Forstbauer, Helmut |
|
utue.personen.roh |
Reimer, Toralf |
|
utue.personen.roh |
Stefek, Andrea |
|
utue.personen.roh |
Fischer, Hans Holger |
|
utue.personen.roh |
Pelz, Enrico |
|
utue.personen.roh |
Zu Eulenburg, Christine |
|
utue.personen.roh |
Kates, Ronald |
|
utue.personen.roh |
Wuerstlein, Rachel |
|
utue.personen.roh |
Kreipe, Hans Heinrich |
|
utue.personen.roh |
Harbeck, Nadia |
|
dcterms.isPartOf.ZSTitelID |
Lancet Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
23 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |